Opioid Abuse Clinical Trial
Official title:
Buprenorphine Induction and Naloxone Distribution Program-Combined With Warm Hand-Off Referral to Continued Treatment
This study is a collaboration between the University of Utah and Castleview Hospital in Price, Utah. Buprenorphine is a medication approved by the FDA to treat Opioid Use Disorder (OUD). Castleview Hospital currently does not prescribe buprenorphine in the emergency department (ED) instead it refers patients to outside addiction treatment facilities. This is a service focused project which the University of Utah will provide mentoring and education to Castleview in implementing an in ED buprenorphine/naloxone distribution program along with referral to continued services. After the program has been implemented, the investigators will evaluate it using quantitative surveys of program participants and qualitative interviews of hospital staff and stakeholders.
Among health care environments, ED often are the front lines of care for those with OUD or who experience opioid overdose. The University of Utah Hospital ED has the Bridge Program which provides buprenorphine and naloxone with warm-hand off referral for continued treatment to people presenting with OUD. In order to extend the services offered by the Bridge Program to rural hospitals, the investigators will be providing mentoring and education to Castleview Hospital in establishing a similar program. Castleview Hospital is the only acute care hospital that serves Carbon and Emery counties, which outside of the Salt Lake City metro area have the highest opioid overdose rates in the State of Utah. This project will utilize both quantitative and qualitative measures to evaluate the impact of this program on patients, hospital staff, and community members. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT04839978 -
Community Trial in the Cherokee Nation
|
N/A | |
| Completed |
NCT05593341 -
Opioid Education in Total Knee Arthroplasty
|
N/A | |
| Terminated |
NCT04495374 -
Oral Pregabalin as Preemptive Analgesia in Abdominal Hysterectomy
|
Phase 4 | |
| Terminated |
NCT03822962 -
Pain Management Following Sinus Surgery
|
Early Phase 1 | |
| Completed |
NCT03936985 -
Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool
|
||
| Active, not recruiting |
NCT01740414 -
Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers
|
Phase 2 | |
| Completed |
NCT00499746 -
The Discriminative Effects of Tramadol in Humans
|
Phase 1/Phase 2 | |
| Completed |
NCT03684681 -
The Navigator Trial
|
N/A | |
| Completed |
NCT04340622 -
Efficacy And Safety Of An Innovative Treatment Of Opiate Use Disorders
|
N/A | |
| Completed |
NCT04018664 -
Oral Abuse Potential Study of Nalbuphine
|
Phase 1 | |
| Completed |
NCT00699010 -
Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid Abuse
|
Phase 2 | |
| Recruiting |
NCT05006079 -
Opioid/Benzodiazepine Polydrug Abuse: Aim 3
|
Phase 2 | |
| Completed |
NCT04710069 -
Postoperative Opt-In Narcotic Treatment Study
|
N/A | |
| Terminated |
NCT03992079 -
A Multimodal Enhanced Recovery Program in Anorectal Surgery
|
N/A | |
| Active, not recruiting |
NCT03570099 -
Naloxone Treatment in Skåne County - Effect on Drug-related Mortality and Overdose-related Complications
|
||
| Completed |
NCT02804152 -
Program for Pain & Prescription Opioid Use in Pregnancy
|
N/A | |
| Active, not recruiting |
NCT01632982 -
Mobile Psychosocial Interventions for MMT Clients
|
N/A | |
| Active, not recruiting |
NCT01136356 -
A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05706311 -
Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool
|
N/A | |
| Completed |
NCT03743493 -
PCORnet Opioid Surveillance Study
|